Blood Cancer Journal Contents: 28 Dec 2021

The latest research from Blood Cancer Journal: 28. December 2021

Transformation and outcome of nodular lymphocyte predominant Hodgkin lymphoma: a Finnish Nationwide population-based study Ilja Kalashnikov , Tomas Tanskanen [...] Sirpa Leppä Article | 18 December 2021 | Article number: 203 |  doi: 10.1038/s41408-021-00586-1

SARS-CoV-2 infection in fully vaccinated patients with multiple myeloma Nicola Sgherza , Paola Curci [...] Pellegrino Musto Correspondence | 14 December 2021 | Article number: 201 |  doi: 10.1038/s41408-021-00597-y

Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies Luis-Esteban Tamariz-Amador , Anna Martina Battaglia [...] Bruno Paiva Article | 14 December 2021 | Article number: 202 |  doi: 10.1038/s41408-021-00594-1

Risk of non-Hodgkin lymphoma in breast cancer survivors: a nationwide cohort study Danbee Kang , Sang Eun Yoon [...] Juhee Cho Article | 14 December 2021 | Article number: 200 |  doi: 10.1038/s41408-021-00595-0

JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis Paola Guglielmelli , Giuseppe G. Loscocco [...] Alessandro M. Vannucchi Article | 11 December 2021 | Article number: 199 |  doi: 10.1038/s41408-021-00581-6

Impact of COVID-19 in patients with multiple myeloma based on a global data network J. Martinez-Lopez , G. Hernandez-Ibarburu [...] J. de la Cruz Article | 10 December 2021 | Article number: 198 |  doi: 10.1038/s41408-021-00588-z

Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial Roberto Mina , Antonietta Pia Falcone [...] Alessandra Larocca Correspondence | 07 December 2021 | Article number: 197 |  doi: 10.1038/s41408-021-00590-5

"Real-life" data of the efficacy and safety of belantamab mafodotin in relapsed multiple myeloma—the Mayo Clinic experience I. Vaxman , J. Abeykoon [...] M. A. Gertz Article | 07 December 2021 | Article number: 196 |  doi: 10.1038/s41408-021-00592-3

Dynamic assessment of measurable residual disease in favorable-risk acute myeloid leukemia in first remission, treatment, and outcomes Sijian Yu , Tong Lin [...] Qifa Liu Article | 06 December 2021 | Article number: 195 |  doi: 10.1038/s41408-021-00591-4

Differentiation therapy for myeloid malignancies: beyond cytotoxicity Ryan J. Stubbins & Aly Karsan Review Article | 04 December 2021 | Article number: 193 |  doi: 10.1038/s41408-021-00584-3

Low NCOR2 levels in multiple myeloma patients drive multidrug resistance via MYC upregulation Tomoaki Mori , Rakesh Verma [...] Noopur S. Raje Article | 04 December 2021 | Article number: 194 |  doi: 10.1038/s41408-021-00589-y

Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage Carlos Fernández de Larrea , Robert Kyle [...] Maria Victoria Mateos Article | 02 December 2021 | Article number: 192 |  doi: 10.1038/s41408-021-00587-0

Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study Saemundur Rognvaldsson , Elias Eythorsson [...] Sigurdur Yngvi Kristinsson Article | 01 December 2021 | Article number: 191 |  doi: 10.1038/s41408-021-00580-7

Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and 18F-FDG PET/CT Hee Jeong Cho , Sung-Hoon Jung [...] Joon Ho Moon Article | 01 December 2021 | Article number: 190 |  doi: 10.1038/s41408-021-00577-2

MPL S505C enhances driver mutations at W515 in essential thrombocythemia Leila N. Varghese , Gonzalo Carreño-Tarragona [...] Stefan N. Constantinescu Correspondence | 29 November 2021 | Article number: 188 |  doi: 10.1038/s41408-021-00583-4

Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism Marko Lucijanic , Ivan Krecak [...] Rajko Kusec Correspondence | 29 November 2021 | Article number: 189 |  doi: 10.1038/s41408-021-00585-2

Is nature truly healing itself? Spontaneous remissions in Paroxysmal Nocturnal Hemoglobinuria Carmelo Gurnari , Simona Pagliuca [...] Jaroslaw P. Maciejewski Correspondence | 27 November 2021 | Article number: 187 |  doi: 10.1038/s41408-021-00582-5

Journal Info Submit Manuscript RSS Feed

This email has been sent to ignoble.experiment@arconati.us by Blood Cancer Journal.

Unsubscribe Manage Alerts Privacy policy Contact us

Springer Nature Limited is a company registered in England and Wales under Company Number 785998 with its registered office at The Campus, 4 Crinan Street, London, N1 9XW, United Kingdom

Nature is part of Springer Nature. © 2021 Springer Nature Limited. All rights reserved.